Purpose Infantile hemangiomas (IHs) are commonly observed benign tumors that can cause
serious complications. M2-polarized macrophages in IHs promote disease progression. In …

Background Though infantile hemangioma (IH) is a common benign vascular tumor, its
pathogenesis remains unclear. This study explored the function of hemangioma-derived …

Background Infantile hemangioma (IH) is the most common benign vascular tumor of infancy
and is proposed to arise from hemangioma stem cells (HemSCs). Therapies for IH include …

Infantile hemangioma (IH) is a common benign tumor of endothelial cells in infants. Most
hemangiomas are self-limited, but a few may develop and lead to serious complications that …

Infantile hemangiomas (IH) are a type of benign vascular neoplasm that may cause
permanent scarring. Hemangioma-derived endothelial cells (HemECs) are commonly used …

Hemangioma (HA) is a type of benign tumor common in infancy. The main feature of HA is
the abnormal proliferation of vascular endothelial cells. To date, the pathogenesis of HA …

Abstract Background: Hemangioma (Hem) is a benign tumor commonly seen in infancy with
a relative high morbidity. Human umbilical vein endothelial cell (HUVEC)-derived …

Background: Hemangioma, which is a benign vascular neoplasm, has been demonstrated
to be the most common tumor of infancy, resulting from aberrant proliferation of endothelial …

Hemangioma (HA), which is characterized by aberrant endothelial cell proliferation in blood
vessels, is a common tumor during infancy. MicroRNAs (miRNAs/miRs) collectively …

Propranolol is the first-line drug for infantile hemangioma (IH) therapy, whereas propranolol
resistance is clinically observed. Tumor-associated macrophages (TAMs)-derived exosomes …